Indraprastha Medical Corporation Ltd Quarterly Results: Standalone & Consolidated Reports

Quarterly Results

Results Snapshot

YoYQoQ

Figures in Cr

Standalone Quarterly Results

Mar'26

Dec'25

Sep'25

Jun'25

Mar'25

Dec'24

Sep'24

Quarterly Analysis Highlights - YoY

Net Sales

YoY Growth in quarter ended Mar 2026 is 9.31% vs 6.04% in Mar 2025

Standalone Net Profit

YoY Growth in quarter ended Mar 2026 is 1.68% vs 31.57% in Mar 2025

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Mar 2026 is -1.32% vs 26.59% in Mar 2025

Interest

YoY Growth in quarter ended Mar 2026 is 0.00% vs -4.49% in Mar 2025

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025

Compare Quarterly Results Of Indrapr.Medical With

Select Peers

Figures in Cr

Standalone Quarterly Results

Change(INR)

Change(%)

Net Sales

364.81

273.79

91.02

33.24%

Other Operating Income

0.00

Total Operating income

364.81

273.79

91.02

33.24%

Raw Material Cost

64.30

0.00

64.30

Purchase of Finished goods

0.00

(Increase) / Decrease In Stocks

0.00

Employee Cost

74.18

43.96

30.22

68.74%

Power Cost

0.00

Manufacturing Expenses

96.59

160.19

-63.60

-39.70%

Selling and Distribution Expenses

0.00

Other Expenses

69.23

19.35

49.88

257.78%

Total Expenditure (Excl Depreciation)

304.30

223.50

80.80

36.15%

Operating Profit (PBDIT) excl Other Income

60.51

50.29

10.22

20.32%

Other Income

7.33

7.68

-0.35

-4.56%

Operating Profit (PBDIT)

67.84

57.97

9.87

17.03%

Interest

1.49

6.31

-4.82

-76.39%

Exceptional Items

0.00

Gross Profit (PBDT)

66.35

51.66

14.69

28.44%

Depreciation

11.34

12.38

-1.04

-8.40%

Profit Before Tax

55.01

39.28

15.73

40.05%

Tax

13.31

9.73

3.58

36.79%

Provisions and contingencies

0.00

Profit After Tax

41.70

29.55

12.15

41.12%

Extraordinary Items

0.00

Prior Period Expenses

0.00

Other Adjustments

0.00

Net Profit

41.70

29.55

12.15

41.12%

Equity Capital

91.67

15.83

75.84

479.09%

Face Value

10.00

1.00

0.00

Reserves

0.00

Earnings per share (EPS)

4.55

1.87

2.68

143.32%

Diluted Earnings per share

4.55

1.87

2.68

143.32%

Operating Profit Margin (Excl OI)

16.59%

18.37%

0.00

-1.78%

Gross Profit Margin

18.19%

18.87%

0.00

-0.68%

PAT Margin

11.43%

10.79%

0.00

0.64%

Public Share Holdings (%)

0.00%

0.00

0.00%

Pledged Promotor Holding (%)

0.00%

0.00

0.00%

Quarterly - Net Sales

Net Sales 364.81 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -1.83% vs -2.47% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 9.31% vs 6.04% in Mar 2025

Quarterly - Standalone Net Profit

Standalone Net Profit 41.70 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 1.71% vs -17.10% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 1.68% vs 31.57% in Mar 2025

Quarterly - Operating Profit (PBDIT)

Operating Profit (PBDIT) 60.51 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is -2.32% vs -13.13% in Dec 2025

YoY Growth in quarter ended Mar 2026 is -1.32% vs 26.59% in Mar 2025

Quarterly - Interest

Interest 1.49 Cr

in Mar 2026

Figures in Cr

QoQ Growth in quarter ended Mar 2026 is 2.05% vs -3.31% in Dec 2025

YoY Growth in quarter ended Mar 2026 is 0.00% vs -4.49% in Mar 2025

Quarterly - Operating Profit Margin (Excl OI)

Operating Profit Margin (Excl OI) 16.59%

in Mar 2026

Figures in %

QoQ Growth in quarter ended Mar 2026 has fallen from Dec 2025

YoY Growth in quarter ended Mar 2026 has fallen from Mar 2025